Skip to main content

Information for Healthcare Providers on the Health Canada Recently Approved Biosimilar For Denosumab

Information for Healthcare Providers on the Health Canada Recently Approved Biosimilar For Denosumab

Original Air Date : October 22, 2024

Original Air Date : October 22, 2024

This webinar for healthcare providers will provide information specific to the Health Canada recently approved biosimilar for denosumab.

Join Dr. Angela Cheung as she speaks to how the denosumab biosimilar compares to the reference drug, what physicians can expect from the clinical results, information on treatment plans, what healthcare providers need to communicate with their patients and more.


PRESENTERS

Dr. Angela Cheung

Dr. Angela Cheung

MD, PhD, FRCPC
Dr. Angela M. Cheung is Professor of Medicine, KY and Betty Ho Chair in Integrative Medicine at University of Toronto and Senior Physician Scientist at University Health Network. She is the Founding Director of the Osteoporosis Program at University Health Network and the Founding Director of the Centre of Excellence in Skeletal Health Assessment at University of Toronto. She obtained her MD from Johns Hopkins University in 1988 and her PhD from Harvard University in 1997. She is a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for >30 years. She has won many research, teaching and mentorship awards over the years, including the 2024 ASBMR Gideon Rodan’s Mentorship Award, the 2023 European Calcified Tissue Society (ECTS) Research Excellence Award, Canadian Institutes of Health Research (CIHR) Senior Investigator award, Canadian Society of Internal Medicine (CSIM) Dr. David Sackett Senior Investigator Award, Ontario Premier Research Excellence Award, University of Toronto (U of T) Eaton Scholar Award in Clinical Research, University Health Network (UHN) Excellence in Clinical Teaching award, U of T Eudenie Stuart Mentorship award and UHN/Sinai Health System Michael Hutcheon Mentorship award. She currently holds a Tier 1 Canada Research Chair in Postmenopausal and Musculoskeletal Health. Dr. Cheung was the past chair of Osteoporosis Canada Scientific Advisory Council. She is a current member of the International Osteoporosis Foundation Council of Scientific Advisors and the President-Elect for International Society of Clinical Densitometry. She has published over 250 peer-reviewed manuscripts and has a h-index of 75. Her research interests are in postmenopausal osteoporosis, atypical femur fractures and rare bone diseases.

MODERATORS

Kerry Grady

Kerry Grady

MHSC, Senior Manager, Scientific and Clinical Programs, Osteoporosis Canada

STAY INFORMED

Get Osteoporosis updates, news and stories. We also inform you of upcoming events and live webinars, don’t miss out, join today!

OC REPLAY WEBINARS – RECENT ITEMS

 Biosimilar for Patients on Denosumab

This webinar will provide you with information about the recently approved biosimilar for denosumab by Health Canada. Join Dr. Teri Charrois who will discuss what a biologic and biosimilar are, how they differ from one another, what you need to know when speaking with your healthcare provider and more.

Information for Healthcare Providers on the Health Canada Recently Approved Biosimilar For Denosumab

This webinar for healthcare providers will provide information specific to the Health Canada recently approved biosimilar for denosumab. Join Dr. Angela Cheung as she speaks to how the denosumab biosimilar compares to the reference drug, what physicians can expect from the clinical results, information on treatment p…

Exercise Recommendations in the New Clinical Practice Guideline

The 2023 Clinical Practice Guideline on the Diagnosis and Management of Osteoporosis in Canada has key recommendations and good practice statements with emphasis on significant areas including exercise. Join Osteoporosis Canada as Dr. Lora Giangregorio shares information on physical activity and exercise for bone hea…
© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001